Fatty liver disease index: A simple screening tool to facilitate diagnosis of nonalcoholic fatty liver disease in the chinese population

Digestive Diseases and Sciences

Volumn 58, Issue 11, 2013, Pages 3326-3334

  Fuyan, Shi ^a,b   Jing, Leng ^c   Wenjun, Cao ^d   Zhijun, Tan ^a   Weijing, Meng ^e   Suzhen, Wang ^b   Yongyong, Xu ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

^c PEOPLE S HOSPITAL OF RIZHAO   (China)

^d Chang Zhi Medical College   (China)

^e Center for Disease Control of Changyi   (China)

Author keywords

Body mass index; Fatty liver disease index; Nonalcoholic fatty liver disease; Propensity score matching; Screening

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; FATTY LIVER DISEASE INDEX; FEMALE; FITNESS; HUMAN; HYPERGLYCEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADULT; CASE-CONTROL STUDIES; CHINA; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; REPRODUCIBILITY OF RESULTS;

EID: 84889585644     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2774-y     Document Type: Article

References (37)

1. Sanyal A. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705-1725.
2. Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol. 2008;14:185-192.
3. Amarapurkar D, Kamani P, Patel N, et al. Prevalence of nonalcoholic fatty liver disease: population based study. Ann Hepatol. 2007;6:161-163.
4. Browning JD, Szczepaniak L, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (Baltimore, MD). 2004;40:1387-1395.
5. Lee J-H, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42:503-508.
6. Fan JG, Zhu J, Li XJ, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol. 2005;43:508-514.
7. Zhongli W, Xia B, Ma C, Hu Z, Chen X, Cao P. Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China. Postgrad Med J. 2007;83:192-195.
8. Arslan U, Türkoglu S, Balcioǧlu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis. 2007;18:433-436.
9. Adams LA, Lymp J, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113-121.
10. Amarapurkar DN, Hashimoto E, Lesmana LA, et al. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22:788-793.
11. Srinivasan D, Jaividhya D, Amer K, Rajesh J, Rocio L, Arthur JM. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol. 2009;51:1061-1067.
12. Shah BR, Laupacis A, Hux JE, Austin PC. Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol. 2005;58:550-559.
13. Rosenbaum PR, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
14. Kurth T, Walker A, Glynn RJ, et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol. 2006;163:262-270.
15. Austin PC. The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies. Stat Med. 2010;29:2137-2148.
16. Steyerberg EW, Harrell FJ, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774-781.
17. Muthén LK, Muthén BO. Mplus 6 [Computer Software]. Los Angeles: Muthén and Muthén; 2010.
18. Katsikatsou M, Moustaki I, Yang-Wallentin F, Jöreskog KG. Pairwise likelihood estimation for factor analysis models with ordinal data. Comput Stat Data Anal. 2012;56:4243-4258.
19. Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285-1293.
20. McLachlan GL. Discriminant analysis and statistical pattern recognition. New York: Wiley; 2005.
21. Hu Y, Li X. Bayes discriminant analysis method to identify risky of complicated goaf in mines and its application. Trans Nonferrous Metals Soc China. 2012;2:425-431.
22. Flora DB, Curran PJ. An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychol Methods. 2004;9:466-491.
23. Browne MW, Cudeck R. Alternative ways of assessing model fit. In: Bollen K, Long JS, eds. Testing structural equation models. Newbury Park: Sage; 1993:136-162.
24. Newcomb MD. Drug use and intimate relationships among women and men: separating specific from general effects in prospective data using structural equation models. J Consult Clin Psychol. 1994;62:463-476.
25. Yu CY, Muthen B. Evaluation of the model fit indices for latent variable models with categorical and continuous outcomes. Paper presented at the annual meeting of the American Educational Research Association; 2002.
26. Cao WJ, Chen C, Hua Y, Li YM, Xu YY, Hua QZ. Factor analysis of a health-promoting lifestyle profile (HPLP): application to older adults in Mainland China. Arch Gerontol Geriatr. 2012;55:632-638.
27. Ramesh S, Sanyal A. Hepatitis C and nonalcoholic fatty liver disease. Semin Liver Dis. 2004;24:399-413.
28. Wieckowska A, Feldstein A. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis. 2008;28:386-395.
29. Duman DG, Celikel C, Tüney D, Imeryüz N, Avsar E, Tözün N. Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment? Dig Dis Sci. 2006;51:346-351.
30. Lee SW, Park S, Kim KW, et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology. 2007;244:479-485.
31. Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol. 2011;21:87-97.
32. Kotronen A, Peltonen M, Hakkarainen A, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 2009;137:865-872.
33. Poynard T, Ratziu V, Naveau S, et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol. 2005;4:10.
34. Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33-39.
35. Graif M, Yanuka M, Baraz M, et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol. 2000;35:319-324.
36. Joseph AE, Saverymuttu S, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43:26-31.
37. Harmon RC, Caldwell S. Propensity for non-alcoholic fatty liver disease: more evidence for ethnic susceptibility. Liver Int. 2009;29:4-5.